<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Rusfertide</title><link>https://peptidescanner.com/peptides/rusfertide/</link><description>Versioned, source-linked PeptideScanner evidence objects for Rusfertide. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/rusfertide.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT04202965</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04202965-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04202965-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct04202965-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-08-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04767802</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04767802-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04767802-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct04767802-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-03-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05210790</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05210790-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05210790-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct05210790-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07648030</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07648030-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07648030-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct07648030-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-02. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07765602</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07765602-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07765602-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct07765602-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-28. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA220605</title><link>https://peptidescanner.com/stories/fda-drugs-nda220605/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda220605:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#fda-drugs-nda220605-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2026-08-28. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-16</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37863080-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37863080-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-37863080-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Rusfertide for iron overload in haemochromatosis - Authors&apos; reply.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38340748-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38340748-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-38340748-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Rusfertide for iron overload in haemochromatosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38340749-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38340749-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-38340749-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42868322-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42868322-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-42868322-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Rusfertide for the treatment of polycythemia vera.</title><link>https://peptidescanner.com/stories/pubmed-pmid-42958870-rusfertide/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-42958870-rusfertide:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-42958870-rusfertide-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
